ABOUT AST
Since 1965, AST has been delivering innovative solutions – many of which were industry firsts and have since become industry standards. AST has always understood that our customers serve demanding and oftentimes unpredictable markets. We also understand that “flexibility is the antidote to uncertainty,” and as your partner, AST consistently seeks to deliver innovative solutions that are robust, yet flexible. AST is a technology leader specializing in advanced aseptic filling and closing systems. Our focus is to provide innovative and flexible products that satisfy the most challenging product and regulatory requirements for the Pharmaceutical and Biotechnology industries. AST’s spectrum of products includes semi-automated to completely automated and integrated cGMP manufacturing systems for processing vials, syringes and cartridges. To discover more about our products please select a product category.
CONTACT INFORMATION
AST
4110 South Washington Street
Tacoma, WA 98409
UNITED STATES
Phone: 253-475-0200
Contact: Brittany Cooksey
FEATURED ARTICLES
-
AST is pleased to welcome two new members to our business development team. Kacie Dennis (right) and Maximilian Kircher (left) joined our team last week and (literally) hit the ground running. They’re already en route to their first tradeshows with AST where, this week, Kacie will be in person at Meeting on the Mesa, and you can find Max in Italy at CPHI Worldwide.
-
AST, a leading provider of flexible aseptic filling systems, has announced the placement of a next-generation GENiSYS® C fill-finish system at the Ascend Advanced Therapies (Ascend) Alachua, FL facility. Ascend is a global gene to GMP gene therapy development partner with 58,500 square feet of recently acquired GMP manufacturing space in Alachua, a rapidly growing biotech hub and birthplace of AAV gene therapy. The new fully automated and isolated filling and closing line will be installed as part of the commercial infrastructure expansion of the Ascend Alachua facility.
-
Drug shortages have increased the burden on compounding pharmacies. Robotics and automation can streamline processes, improve accuracy, and ensure quality to address challenges faced by these facilities.
-
How should you approach building your aseptic processing line? Explore the advantages of using a modular, configurable technology.
-
AST is excited to introduce Sean Silvey, who is joining us as Product Manager. Sean has been leading critical product development and technical communication initiatives for over a decade and has an extensive background in mechanical engineering. Sean has a passion for connecting creative problem-solving and strategic thinking with customer-centered solutions. As part of AST’s product development team, Sean will play an integral part in product implementation, forecasting, market intelligence, and identifying opportunities for innovation within the life science industry.
-
The revised Annex 1 focuses on harmonizing regulations across the pharmaceutical manufacturing industry, prompting the pharmaceutical industry to strategize to achieve the best compliance method.
-
Learn about a flexible aseptic processing system that provides modular, semi-automated, and fully automated solutions to meet demands at all stages of development.
-
Learn about a modular and compact filling and closing system for flexibility in pharmaceutical manufacturing operations and automated processing of vials, syringes, and cartridges.
-
How can you address the decontamination challenges associated with isolated fill-finish operations? New innovations are being implemented to ensure superior sporicidal reduction and operational safety.
-
When it come to fill-finish manufacturing of parenteral liquid pharmaceuticals, your choice of barrier technology is crucial.
-
Learn about the development process behind a new, state-of-the-art fill-finish isolator that's addressing issues in isolator manufacturing and servicing, as well as meeting the needs of the liquid pharmaceutical market.
-
CURIS System, an innovator in advanced decontamination technology, and AST, a leader in aseptic fill-finish processing technology, today announced a groundbreaking partnership. This collaboration marks a significant step forward in the pharmaceutical manufacturing industry, as the two companies combine technology to revolutionize the biodecontamination of aseptic fill-finish isolators using CURIS's disruptive vapor decontamination technology.
-
AST has over 50 years of experience designing, manufacturing, and servicing innovative, high quality and highly automated processing equipment. Beginning in 2006, AST leveraged our experience and close customer relationships to revolutionize the aseptic fill/finish industry with the launch of the ASEPTiCell® development.
-
The path to a successful life science startup is exciting, difficult, and unpredictable. Recent years have seen a volatile pattern emerge of challenge, change and innovation within the life sciences.
-
Aseptic fill-finish professionals are continually looking to augment their approach to a market that continues to grow and reflect innovations happening around sterile parenteral treatments.
-
Establishing early and clear tech transfer strategies is a key component of a holistic approach to drug development. Learn about the role that capable fill-finish solutions play in this process.
-
One of the most intriguing, high-stakes aspects of R&D is the realm of biosimilars. Explore the challenges of biosimilar production as well as aseptic processing considerations for biosimilars.
-
Germfree Laboratories, a global leader in isolator technology for aseptic processing and containment in the pharmaceutical sector, and AST, a pioneer in aseptic fill-finish processing technology, are thrilled to announce a revolutionary partnership. This landmark collaboration is set to redefine industry standards, launching a new era of innovation and efficiency.
-
Here, we share one of the best ways to ensure sterility in aseptic compounding operations and how 503A and 503B pharmacies can achieve the adaptability they need to scale their operation.
-
Explore best aseptic practices for cell and gene therapy production that will be foundational to the ongoing development of these therapies as well as their successful manufacturing operations.
AST VIDEOS
-
View this demonstration of a flexible, modular fill-finish machine featuring a fully integrated HMI and automated processing of nested, custom, and ready-to-use vials, syringes, and cartridges.
-
Gain advanced and intuitive solutions for automated aseptic processing of liquid pharmaceutical products with a system designed for small-scale filling applications.
-
Designed with the specific challenges of small-batch production in mind, this aseptic processing system can be customized to meet the needs of your facility.
-
Watch as Josh Russell, VP of Sales and Marketing, AST, demonstrates the GENiSYS® C aseptic filling system, ideal for use in small-scale filling applications.
-
Josh Russell, VP of Sales & Marketing, describes the AST Quick Delivery program, which makes certain isolated fill finish equipment available within six months of purchase.
-
Join Keith Dodson of Automated Systems to discover small batch aseptic solutions for cell therapy, gene therapy, vaccines, R&D, biosimilars and CDMO’s.
-
The 4th generation GENiSYS C is an advanced yet compact solution for automated aseptic processing of liquid pharmaceutical products, with many features typically reserved for large scale filling lines. Learn more in our latest video.
-
ASEPTiCell provides flexible, robotic filling and finishing of vials, syringes and cartridges for small to medium clinical and commercial batches. The modular design allows the ASEPTiCell to be built to your specification without the cost and risk of customization.
-
AST’s GENiSYS® Lab semi-automatic systems are ideal for drug product development and cGMP production applications. Each system automates the critical aseptic operations for vial, syringe and cartridge processing to reduce contamination risk and product variability. GENiSYS Lab offers a perfect balance between automated features, size and affordability without compromising quality, safety and ease of use.
-
Is the general opinion about robotics improving? Watch this webinar to learn more about where and how robotics add value and solve problems.
-
This presentation addresses the changing needs for the manufacturing of biologics and the rationale for the use of robotics and automation in aseptic fill and finish processing of these products.